CartiHeal was founded at Peregrine's Incubator back in 2009 as a joint venture with the Ben Gurion university Ribon Therapeutics is a clinical-stage biotechnology company developing therapeutics targeting novel enzyme families activated under cellular stress conditions that contribute to disease. Medtech company CartiHeal is being acquired by Nasdaq-traded Bioventus for a sum estimated at $500 million. Bioventus announced on Monday that it has elected to make a $50 million es